| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $9.44 (Miss by $-0.020000000000001) |
| EPS GAAP Actual | $9.44 (Miss by $-0.020000000000001) |
| Revenue Actual | $4.425B |
| Revenue Surprise | Beat by $4425M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $11.0633 |
| EPS GAAP Estimate | $11.0633 |
| Revenue Estimate | $5.059075033B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 55.97 | 21.26 | 55.20993 | 56.83986 | 1 |
| Dec 2028 | 54.7 | 21.76 | 53.87517 | 56.13996 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 9.45 | -1.786 | 4.425B | 4.34% | -348.76M |
| FQ3 2025 (Sep 2025) | 6.1 | -4.652 | 4.657B | 5.78% | -6.74M |
| FQ2 2025 (Jun 2025) | 9.99 | -0.676 | 4.554B | 5.31% | -108.58M |
| FQ1 2025 (Mar 2025) | 9.88 | 9.88 | 4.306B | 1.65% | 4306M |
| FQ4 2024 (Dec 2024) | 9.77 | 9.77 | 4.233B | 5.58% | 4233M |
| FQ3 2024 (Sep 2024) | 9.96 | 9.96 | 4.388B | 4.1% | 4388M |
| FQ2 2024 (Jun 2024) | 9.59 | 9.59 | 4.312B | 3.01% | 4312M |
| FQ1 2024 (Mar 2024) | 9.72 | 9.72 | 4.235B | 3.4% | 4235M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
11.0633
Consensus Revenue Estimates
5.059075033B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 11.36 | -- | 11.22707 | 11.4537 | 6 |
| FQ3 2027 (Sep 2027) | 12.8466 | -- | 12.68604 | 13.13923 | 4 |
| FQ2 2027 (Jun 2027) | 11.7949 | -- | 11.64748 | 12.06357 | 3 |
| FQ1 2027 (Mar 2027) | 11.0111 | -- | 10.89461 | 11.23269 | 4 |
| FQ4 2026 (Oct 2026) | 12.178 | 22.4 | 12.02531 | 12.30029 | 3 |
| FQ3 2026 (Jul 2026) | 11.2487 | 45.77 | 11.10766 | 11.36166 | 3 |
| FQ2 2026 (Jun 2026) | 11.2487 | 11.19 | 11.2487 | 11.2487 | 3 |
| FQ1 2026 (Mar 2026) | 11.0633 | 10.7 | 11.0633 | 11.0633 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 5.03B | -- | 4.98B | 5.06B | 14 |
| FQ3 2027 (Sep 2027) | 5.44B | -- | 5.39B | 5.54B | 5 |
| FQ2 2027 (Jun 2027) | 5.32B | -- | 5.27B | 5.41B | 5 |
| FQ1 2027 (Mar 2027) | 5.24B | -- | 5.2B | 5.32B | 5 |
| FQ4 2026 (Oct 2026) | 5.32B | 16.84 | 5.27B | 5.36B | 4 |
| FQ3 2026 (Jul 2026) | 5.2B | 10.46 | 5.15B | 5.24B | 4 |
| FQ2 2026 (Jun 2026) | 5.18B | 12.01 | 5.18B | 5.18B | 4 |
| FQ1 2026 (Mar 2026) | 5.06B | 14.89 | 5.06B | 5.06B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 11.236 | 9.45 | -1.786 | -18.9% |
| FQ3 2025 (Sep 2025) | 10.752 | 6.1 | -4.652 | -76.26% |
| FQ2 2025 (Jun 2025) | 10.666 | 9.99 | -0.676 | -6.77% |
| FQ1 2025 (Mar 2025) | 9.88 | 9.88 | 100% | |
| FQ4 2024 (Dec 2024) | 9.77 | 9.77 | 100% | |
| FQ3 2024 (Sep 2024) | 9.96 | 9.96 | 100% | |
| FQ2 2024 (Jun 2024) | 9.59 | 9.59 | 100% | |
| FQ1 2024 (Mar 2024) | 9.72 | 9.72 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $4.77B | $4.43B | $-348.76M | -7.88% |
| FQ3 2025 (Sep 2025) | $4.66B | $4.66B | $-6.74M | -0.14% |
| FQ2 2025 (Jun 2025) | $4.66B | $4.55B | $-108.58M | -2.38% |
| FQ1 2025 (Mar 2025) | $0B | $4.31B | $4306M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $4.23B | $4233M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.39B | $4388M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $4.31B | $4312M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $4.24B | $4235M | 100% |